Which of the following statements is true regarding the use of activated protein C in the treatment of severe sepsis?
Explanation
Activated protein C, also known as drotrecogin alfa, was used to reduce mortality in severe sepsis by inhibiting coagulation and inflammation, although its use has been discontinued due to lack of efficacy and safety concerns.
Source
NEJM, 2001; 345:699-709











